Interpregnancy interval and adverse birth outcomes: a population-based cohort study of twins

被引:0
|
作者
Dhamrait, Gursimran [1 ,2 ]
O'Donnell, Melissa [1 ,3 ]
Christian, Hayley [1 ,2 ]
Taylor, Catherine L. [1 ,4 ]
Pereira, Gavin [1 ,5 ,6 ,7 ]
机构
[1] Univ Western Australia, Telethon Kids Inst, 15 Hosp Ave,POB 855, Nedlands, WA 6872, Australia
[2] Univ Western Australia, Sch Populat & Global Hlth, Nedlands, WA, Australia
[3] Univ South Australia, Australian Ctr Child Protect, Adelaide, SA, Australia
[4] Univ Western Australia, Ctr Child Hlth Res, Nedlands, WA, Australia
[5] Curtin Univ, Curtin Sch Populat Hlth, Perth, Australia
[6] Norwegian Inst Publ Hlth, Ctr Fertil & Hlth CeFH, Oslo, Norway
[7] Curtin Univ, enAble Inst, Perth, WA, Australia
基金
澳大利亚研究理事会;
关键词
Interpregnancy intervals; Low birth weight; Preterm birth; Early preterm birth; Small for gestational age; Record linkage; Twins; Australia; PREGNANCIES; HEALTH;
D O I
10.1186/s12884-023-06119-x
中图分类号
R71 [妇产科学];
学科分类号
100211 ;
摘要
Background To investigate associations between interpregnancy intervals (IPIs) and adverse birth outcomes in twin pregnancies. Methods This retrospective cohort study of 9,867 twin pregnancies in Western Australia from 1980-2015. Relative Risks (RRs) were estimated for the interval prior to the pregnancy (IPI) as the exposure and after the pregnancy as a negative control exposure for preterm birth (< 37 weeks), early preterm birth (< 34 weeks), small for gestational age (SGA: < 10(th) percentile of birth weight by sex and gestational age) and low birth weight (LBW: birthweight < 2,500 g). Results Relative to IPIs of 18-23 months, IPIs of < 6 months were associated with a higher risk of early preterm birth (aRR 1.41, 95% CI 1.08-1.83) and LBW for at least one twin (aRR 1.16, 95% CI 1.06-1.28). IPIs of 6-11 months were asso-ciated with a higher risk of SGA (aRR 1.24, 95% CI 1.01-1.54) and LBW for at least one twin (aRR 1.09, 95% CI 1.01-1.19). IPIs of 60-119 months and >= 120 months were associated with an increased risk of preterm birth (RR 1.12, 95% CI 1.03-1.22; and (aRR 1.25, 95% CI 1.10-1.41, respectively), and LBW for at least one twin (aRR 1.17, 95% CI 1.08-1.28; and aRR 1.20, 95% CI 1.05-1.36, respectively). IPIs of >= 120 months were also associated with an increased risk of early preterm birth (aRR 1.42, 95% CI 1.01-2.00). After negative control analysis, IPIs >= 120 months remained associated with early preterm birth and LBW. Conclusion Evidence for adverse associations with twin birth outcomes was strongest for long IPIs.
引用
收藏
页数:13
相关论文
共 50 条
  • [21] Association of adverse birth outcomes with prenatal uranium exposure: A population-based cohort study
    Zhang, Weiping
    Liu, Wenyu
    Bao, Shuangshuang
    Liu, Hongxiu
    Zhang, Yuzeng
    Zhang, Bin
    Zhou, Aifen
    Chen, Jia
    Hao, Ke
    Xia, Wei
    Li, Yuanyuan
    Sheng, Xia
    Xu, Shunqing
    ENVIRONMENT INTERNATIONAL, 2020, 135
  • [22] Epidural analgesia during birth and adverse neonatal outcomes: A population-based cohort study
    Hotoft, Diana
    Maimburg, Rikke Damkjaer
    WOMEN AND BIRTH, 2021, 34 (03) : e286 - e291
  • [23] Association between interpregnancy interval and adverse perinatal outcomes among subsequent twin pregnancies: a nationwide population-based study
    Ye, Shaoxin
    Huang, Xuqiong
    Fan, Dazhi
    Chen, Gengdong
    Li, Pengsheng
    Rao, Jiaming
    Zhou, Zixing
    Guo, Xiaoling
    Liu, Zhengping
    Lin, Dongxin
    AMERICAN JOURNAL OF OBSTETRICS & GYNECOLOGY MFM, 2024, 6 (09)
  • [24] Effect of interpregnancy interval on adverse birth outcomes in China from 2000 to 2015: a large retrospective cohort study
    Zhang, Lifang
    Shen, Songying
    Chan, Fanfan
    Lu, Jinhua
    Wen, Xingxuan
    Li, Weidong
    Xia, Xiaoyan
    Wang, Ping
    Mo, Weijian
    Chen, Niannian
    Xiao, Wanqing
    Li, Shenghui
    Lam, Kin Bong Hubert
    Mol, Ben Willem J.
    Xia, Huimin
    Qiu, Xiu
    AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY, 2017, 216 (01) : S293 - S293
  • [25] Antiseizure Medication Use in Pregnancy and Adverse Neonatal Birth Outcomes: A Population-Based Cohort Study
    Lavu, A.
    Peymani, P.
    Alessi-Severini, S.
    Ruth, C.
    Falk, J.
    Haidar, L.
    Aboulatta, L.
    Akinola, S.
    Farooq, F.
    Kowalec, K.
    Leong, C.
    Derksen, S.
    Ng, M.
    Delaney, J.
    Kaul, P.
    Eltonsy, S.
    BIRTH DEFECTS RESEARCH, 2023, 115 (08): : 882 - 882
  • [26] Association between interpregnancy interval and pregnancy complications by history of complications: a population-based cohort study
    Gebremedhin, Amanuel Tesfay
    Tessema, Gizachew Assefa
    Regan, Annette K.
    Pereira, Gavin F.
    BMJ OPEN, 2021, 11 (12):
  • [27] Gabapentin Use during Pregnancy and Adverse Neonatal Birth Outcomes: A Population-Based Cohort Study
    Lavu, A.
    Peymani, P.
    Severini, S. Alessi
    Ruth, C.
    Falk, J.
    Aboulatta, L.
    Haidar, L.
    Akinola, P. S.
    Farooq, F.
    Kowalec, K.
    Derksen, S.
    Leong, C.
    NG, M.
    Kaul, P.
    Delaney, J.
    Eltonsy, S.
    BIRTH DEFECTS RESEARCH, 2023, 115 (08): : 873 - 873
  • [28] Gabapentin use during pregnancy and adverse neonatal birth outcomes: A population-based cohort study
    Lavu, Alekhya
    Peymani, Payam
    Alessi-Severini, Silvia
    Ruth, Chelsea
    Falk, Jamison
    Kowalec, Kaarina
    Leong, Christine
    Haidar, Lara
    Aboulatta, Laila
    Akinola, Pelumi Samuel
    Farooq, Faiza
    Derksen, Shelley
    Ng, Marcus C.
    Kaul, Padma
    Delaney, Joseph
    Eltonsy, Sherif
    PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2023, 32 : 520 - 521
  • [29] Gabapentin use during pregnancy and adverse neonatal birth outcomes: a population-based cohort study
    Lavu, A.
    Peymani, P.
    Alessi-Severini, S.
    Ruth, C.
    Falk, J.
    Kowalec, K.
    Leong, C.
    Derksen, S.
    Ng, M. C.
    Delaney, J.
    Eltonsy, S.
    EPILEPSIA, 2023, 64 : 21 - 21
  • [30] Antiseizure medication use in pregnancy and adverse neonatal birth outcomes: A population-based cohort study
    Lavu, Alekhya
    Peymani, Payam
    Alessi-Severini, Silvia
    Ruth, Chelsea
    Falk, Jamison
    Kowalec, Kaarina
    Leong, Christine
    Aboulatta, Laila
    Haidar, Lara
    Farooq, Faiza
    Akinola, Pelumi Samuel
    Derksen, Shelley
    Ng, Marcus C.
    Kaul, Padma
    Delaney, Joseph
    Eltonsy, Sherif
    PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2023, 32 : 516 - 517